November 28, 2016
Japanese prosecutors on November 25 demanded a two-and-a-half year prison sentence for a former employee of Novartis Pharma, who allegedly manipulated data in a post-registration clinical trial involving the company’s hypertension drug Diovan (valsartan). In the Tokyo District Court, the...read more